Feilding, Manawatū-Whanganui Region, North Island, New Zealand

🇳🇿 Feilding is a town in the Manawatu District of the North Island of New Zealand. It is located on State Highway 54, 20 km north of Palmerston North. The town is the seat of the Manawatu District Council.

Feilding has won the annual New Zealand's Most Beautiful Town award 16 times. It is an Edwardian-themed town, with the district plan encouraging buildings in the CBD to be built in that style. The town is currently extending its CBD beautification featuring paving and planter boxes on the footpaths on the main streets in the CBD, including the realignment and beautification of Fergusson Street to the South Street entrance of Manfeild Park.

The town is a service town for the surrounding farming district. The Feilding Saleyards have been a vital part of the wider Manawatu community for over 125 years. As transport systems improved and farming practices changed, the need for small, local saleyards all but disappeared, leaving few major selling complexes in New Zealand. Manawatu is a diverse and fertile farming area with high production, high stock-carrying capacity and a stable climate. These factors make Feilding Saleyards a popular medium for many farmers. A unique aspect of Feilding Saleyards is their location in the centre of town.

The Manawatu Plains, on which the town is sited, are very fertile land, and as such it is a prosperous agricultural area. Being located on the floodplain of a major river has its problems, however, and in February 2004 the town suffered extensive flooding. In 2009 the Horizons Regional Council commissioned a new flood protection scheme to prevent extensive flooding in the future.

Economy Employing about 30 people with a payroll of $1.5m in 2015, Proliant, an Iowa based firm privately held by the father and son team of Wally and Nix Lauridsen, constructed a $24m factory on the outskirts of Feilding for the production of a by-product from cattle blood plasma, bovine serum albumin (BSA), which is used in pharmaceuticals, vaccines and medical research. Proliant produces about half of the world's BSA.